 |
|
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray
Clin Mol Hepatol. 2020;26(4):383-400. Published online 2020 Jul 17 DOI: https://doi.org/10.3350/cmh.2020.0067
|
|
Citations to this article as recorded by
 A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Naim Alkhouri, Katherine Edwards, Mark Berman, Heather Finn, Rafael Escandon, Paul Lupinacci, Nicole Guthrie, Angie Coste, Jesus Topete, Mazen Noureddin
Gastro Hep Advances.2024; 3(1): 9. CrossRef The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial
Mohammad Alizadeh, Mohammadreza Mohammad Hosseiniazar, Farkhondeh Alami, Somayyeh Bararnia Adabi
Journal of Diabetes & Metabolic Disorders.2024;[Epub] CrossRef Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
Carolin V. Schneider, Kai Markus Schneider, Anastasia Raptis, Helen Huang, Christian Trautwein, Rohit Loomba
Alimentary Pharmacology & Therapeutics.2024;[Epub] CrossRef Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells
Jin-Mei Yao, Hua-Zhong Ying, Huan-Huan Zhang, Fen-Sheng Qiu, Jun-Qi Wu, Chen-Huan Yu
Free Radical Biology and Medicine.2023; 195: 58. CrossRef Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
Simona Cernea, Danusia Onișor
World Journal of Gastroenterology.2023; 29(2): 286. CrossRef Multi-omics analysis of the effects of dietary changes and probiotics on diet-induced obesity
Shiman Jiang, Yuanshuai Su, Qiangqiang Wang, Longxian Lv, Chen Xue, Lvwan Xu, Lanjuan Li
Current Research in Food Science.2023; 6: 100435. CrossRef Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
Yoon-a Hwang, Hye Won Lee, Sang Hoon Ahn, Eun Jig Lee, Cheol Ryong Ku, Seung Up Kim
Frontiers in Endocrinology.2023;[Epub] CrossRef Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clinical and Molecular Hepatology.2023; 29(1): 179. CrossRef Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis
Heechul Nam, Jeong-Ju Yoo, Yuri Cho, Seong Hee Kang, Sang Bong Ahn, Hye-Won Lee, Dae Won Jun, Do Seon Song, Miyoung Choi
Digestive and Liver Disease.2023; 55(9): 1178. CrossRef Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
Anja Geerts, Sander Lefere
Clinical and Molecular Hepatology.2023; 29(Suppl): S276. CrossRef Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Asako Nogami, Masato Yoneda, Michihiro Iwaki, Takashi Kobayashi, Yasushi Honda, Yuji Ogawa, Kento Imajo, Satoru Saito, Atsushi Nakajima
Clinical and Molecular Hepatology.2023; 29(Suppl): S123. CrossRef Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
Jihyun An, Joo Hyun Sohn
Clinical and Molecular Hepatology.2023; 29(Suppl): S268. CrossRef The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Young-Joo Jin
Clinical and Molecular Hepatology.2023; 29(2): 414. CrossRef The growing burden of non-alcoholic fatty liver disease on mortality
Ju-Yeon Cho, Won Sohn
Clinical and Molecular Hepatology.2023; 29(2): 374. CrossRef Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Clinical and Molecular Hepatology.2023; 29(2): 433. CrossRef Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Sergio Castorina, Stefano Puleo, Martina Barchitta, Antonella Agodi, Luisa Gallo, Gaetano La Greca, Saverio Latteri
Biology.2023; 12(5): 662. CrossRef PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL
Silvia Massami YOSHIMURA, Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Daniel Ferraz de Campos MAZO, João Renato Rebello PINHO, Claudia P OLIVEIRA
Arquivos de Gastroenterologia.2023; 60(1): 98. CrossRef Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease
Margalida Monserrat-Mesquida, Maria Magdalena Quetglas-Llabrés, Cristina Bouzas, Oscar Pastor, Lucía Ugarriza, Isabel Llompart, Karla Cevallos-Ibarra, Antoni Sureda, Josep A. Tur
Antioxidants.2023; 12(8): 1554. CrossRef Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Eileen L. Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(4): 1050. CrossRef Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders.2023; 24(6): 1189. CrossRef Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagström, Terry T.-K. Huang, Mona H. Isma
Nature Reviews Gastroenterology & Hepatology.2022; 19(1): 60. CrossRef Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway
Alina Abdolahi, Zakaria Vahabzadeh, Esmael Izadpanah, Mohammad Raman Moloudi
Journal of Physiology and Biochemistry.2022; 78(1): 185. CrossRef Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study
Xiaofen Xie, Bing Guo, Xiong Xiao, Jianzhong Yin, Ziyun Wang, Xiaoman Jiang, Jingzhong Li, Lu Long, Junmin Zhou, Ning Zhang, Yuan Zhang, Ting Chen, Baima Kangzhuo, Xing Zhao
BMC Public Health.2022;[Epub] CrossRef Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!
Niki Katsiki, Anca Pantea Stoian, Manfredi Rizzo
Clínica e Investigación en Arteriosclerosis.2022; 34: S24. CrossRef Dietary Patterns and Prevalent NAFLD at Year 25 from the Coronary Artery Risk Development in Young Adults (CARDIA) Study
Meagan E. Gray, Sejong Bae, Rekha Ramachandran, Nicholas Baldwin, Lisa B. VanWagner, David R. Jacobs, James G. Terry, James M. Shikany
Nutrients.2022; 14(4): 854. CrossRef Impact of SARS-CoV-2 Lockdown on the Preoperative Care Program of Patients Scheduled for Bariatric Surgery
Luigi Schiavo, Pietro Calabrese, Silvana Mirella Aliberti, Salvatore Tramontano, Antonio Iannelli, Vincenzo Pilone
Nutrients.2022; 14(7): 1488. CrossRef Renaming NAFLD to MAFLD: Advantages and Potential Changes in Diagnosis, Pathophysiology, Treatment, and Management
Fajuan Rui, Hongli Yang, Xinyu Hu, Qi Xue, Yayun Xu, Junping Shi, Jie Li
Infectious Microbes and Diseases.2022; 4(2): 49. CrossRef Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!
Niki Katsiki, Anca Pantea Stoian, Manfredi Rizzo
Clínica e Investigación en Arteriosclerosis (English Edition).2022; 34: 23. CrossRef Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study
Sofía Montemayor, Catalina M. Mascaró, Lucía Ugarriza, Miguel Casares, Isabel Llompart, Itziar Abete, María Ángeles Zulet, J. Alfredo Martínez, Josep A. Tur, Cristina Bouzas
Nutrients.2022; 14(15): 3186. CrossRef Physiopathology of nonalcoholic fatty liver disease: from diet to nutrigenomics
Paola Meneghel, Elisa Pinto, Francesco Paolo Russo
Current Opinion in Clinical Nutrition & Metabolic Care.2022; 25(5): 329. CrossRef Holistic Approach in the Management of Nonalcoholic Fatty Liver Disease
Ananta Shrestha, Shrijana Pradhananga
Euroasian Journal of Hepato-Gastroenterology.2022; 12(S1): S51. CrossRef Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Tuo Lin, Xin M. Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi N
Journal of Hepatology.2022; 77(6): 1482. CrossRef Implementation of a Whole Food Plant Based Diet in a Food as Prevention Program in a Resource Constrained Environment
Subhas C. Ganguli, Lindsey A. Russell, Keith S. Tsoi
Journal of Lifestyle Medicine.2022; 12(3): 148. CrossRef Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen
Nutrients.2022; 14(21): 4556. CrossRef Metabolic drivers of non-alcoholic fatty liver disease
Kendra K. Bence, Morris J. Birnbaum
Molecular Metabolism.2021; 50: 101143. CrossRef Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
Pau Vancells Lujan, Esther Viñas Esmel, Emilio Sacanella Meseguer
Nutrients.2021; 13(5): 1442. CrossRef Integrative Behandlungsansätze bei chronischen Lebererkrankungen
Roman Huber
Zeitschrift für Komplementärmedizin.2021; 13(02): 14. CrossRef Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome
Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo
Clinical and Molecular Hepatology.2021; 27(3): 463. CrossRef Defining comprehensive models of care for NAFLD
Jeffrey V. Lazarus, Quentin M. Anstee, Hannes Hagström, Kenneth Cusi, Helena Cortez-Pinto, Henry E. Mark, Michael Roden, Emmanuel A. Tsochatzis, Vincent Wai-Sun Wong, Zobair M. Younossi, Shira Zelber-Sagi, Manuel Romero-Gómez, Jörn M. Schattenberg
Nature Reviews Gastroenterology & Hepatology.2021; 18(10): 717. CrossRef Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial
Won Myung Lee, Jea Hurn Bae, Young Chang, Sae Hwan Lee, Ji Eun Moon, Soung Won Jeong, Jae Young Jang, Sang Gyune Kim, Hong Soo Kim, Jeong-Ju Yoo, Young Seok Kim
Nutrients.2021; 13(12): 4453. CrossRef Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors
Sunyoung Lee, Kyoung Won Kim, Jeongjin Lee, Taeyong Park, Hyo Jung Park, Gi‐Won Song, Sung‐Gyu Lee
Liver Transplantation.2021; 27(10): 1424. CrossRef Influence of Dietary Behaviors on Dyslipidemia in Pregnant Women and Its Effects on Physical Development of Fetuses and Infants: A Bidirectional Cohort Study
Chenyang Li, Xuening Li, Dan Wu, Qi Chen, Zhe Xiao, Deliang Wen, Lingling Zhai, Lihong Jia
Nutrients.2021; 13(10): 3398. CrossRef The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression
MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam
Diabetes Research and Clinical Practice.2021; 178: 108951. CrossRef Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice
Kyung-A Byun, Seyeon Oh, Myeongjoo Son, Chul-Hyun Park, Kuk Hui Son, Kyunghee Byun
Marine Drugs.2021; 19(9): 495. CrossRef Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome
Markus Rohner, Robert Heiz, Simon Feldhaus, Stefan R. Bornstein
Hormone and Metabolic Research.2021; 53(08): 529. CrossRef Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease
Galal A. AL-SAMHARI, Gaber M. AL-MUSHIKI, Rashi TAMRAKAR, Gibirima ABDULLAHI, YUE-Dong LIN, XIAN-Yan TANG
Journal of Nutritional Science and Vitaminology.2021; 67(6): 366. CrossRef KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Wo
Clinical and Molecular Hepatology.2021; 27(3): 363. CrossRef The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
Ajit Venniyoor, Abdul Aziz Al Farsi, Bassim Al Bahrani
Cureus.2021;[Epub] CrossRef
|